ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,484Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 973

$885K Total Retail Price of All Prescriptions

Rank: 16 out of 973

454 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

22% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 10,166 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 644 418 1 2
SIMVASTATIN 603 415 2 1
METFORMIN HCL 598 335 3 8
HYDROCODONE-ACETAMINOPHEN 556 308 S3 4 4
FUROSEMIDE 555 407 5 6
LISINOPRIL 518 372 6 3
AMLODIPINE BESYLATE 400 286 7 7
GABAPENTIN 365 256 8 12
OMEPRAZOLE 330 171 9 5
TRAMADOL HCL 326 193 10 18
WARFARIN SODIUM 286 249 11 10
POTASSIUM CHLORIDE 258 182 12 9
ATORVASTATIN CALCIUM 233 156 13 15
MELOXICAM 227 122 14 23
METOPROLOL SUCCINATE 216 137 15 17
SERTRALINE HCL 214 147 16 21
GLYBURIDE 206 118 R 17 59
HYDROCHLOROTHIAZIDE 192 155 18 11
RISPERIDONE 169 40 19 65
DIVALPROEX SODIUM 166 98 20 86
NAMENDA 165 157 21 31
GLIMEPIRIDE 163 125 22 41
METOPROLOL TARTRATE 162 110 23 13
TRAZODONE HCL 161 102 24 48
ATENOLOL 158 131 25 16
LANTUS 153 76 26 39
CYMBALTA 147 74 27 40
AZITHROMYCIN 146 87 28 47
CARBIDOPA-LEVODOPA 146 118 28 71
MIRTAZAPINE 132 99 30 43
DONEPEZIL HCL 129 127 31 26
CITALOPRAM HBR 121 107 32 14
CEPHALEXIN 118 67 33 75
QUETIAPINE FUMARATE 116 80 34 70
PANTOPRAZOLE SODIUM 114 79 35 37
CRESTOR 114 51 35 34
NEXIUM 103 34 37 30
SULFAMETHOXAZOLE-TRIMETHOPRIM 103 78 37 76
AMOXICILLIN 102 80 39 101
RANITIDINE HCL 94 53 40 45
PRAVASTATIN SODIUM 90 69 41 22
OLANZAPINE 90 31 41 122
BENZTROPINE MESYLATE 89 38 R 43 124
PHENYTOIN SODIUM EXTENDED 89 21 43 141
DOXYCYCLINE HYCLATE 89 55 43 96
ISOSORBIDE MONONITRATE ER 87 46 46 85
PROMETHAZINE HCL 86 25 R 47 138
CLOPIDOGREL 84 75 48 44
TAMSULOSIN HCL 84 39 48 28
ALENDRONATE SODIUM 83 83 50 24
SPIRIVA 82 40 51 73
PROAIR HFA 81 53 52 54
BENAZEPRIL HCL 80 57 53 62
TRIAMCINOLONE ACETONIDE 79 52 54 120
LAMOTRIGINE 78 21 55 175
SPIRONOLACTONE 74 49 56 49
PREDNISONE 74 55 56 33
CARVEDILOL 73 54 58 27
PAROXETINE HCL 73 20 58 66
POLYETHYLENE GLYCOL 3350 73 39 58 36
ZOLPIDEM TARTRATE 73 29 58 20
PROPRANOLOL HCL 73 20 58 97
ABILIFY 73 23 58 146
ACETAMINOPHEN-CODEINE 72 21 S3 64 134
FENTANYL 69 69 S2 65 53
ENALAPRIL MALEATE 67 51 66 55
VENTOLIN HFA 66 26 67 180
CARBAMAZEPINE 65 0 68 165
HALOPERIDOL 65 35 68 176
ADVAIR DISKUS 63 41 70 60
PLAVIX 63 56 70 78
NOVOLOG 62 37 72 82
CLONIDINE HCL 61 17 73 67
BACLOFEN 59 0 74 123
MUPIROCIN 58 40 75 151
LOSARTAN POTASSIUM 57 31 76 19
LANTUS SOLOSTAR 57 30 76 99
GEMFIBROZIL 55 18 78 83
ESCITALOPRAM OXALATE 55 27 78 68
LIPITOR 55 44 78 139
EXELON 54 54 81 117
DIOVAN 53 43 82 63
ROPINIROLE HCL 52 41 83 72
SYMBICORT 50 34 84 163
FINASTERIDE 50 13 84 90
TRICOR 50 0 84 143
FLUOXETINE HCL 50 32 84 56
ALLOPURINOL 50 37 84 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.